MYBL2 and hepatocellular carcinoma: Our results were in line with limited evidence that IMPDH1 expression represent worse clinical outcomes, while combining MYBL2 and IMPDH1 together, prognosis gap is larger, indicting they were important in HCC progression, and there is a synergy between the two.